Raymond Oh

Recent M&A/private equity experience includes the representation of*:

• Hennessy Capital Investment Corp., a publicly traded special purpose acquisition company, in its agreement to combine with Plus (formerly Plus.ai), a global provider of self-driving truck technology, with an implied pro forma equity value of US$3.3 billion.
• GOME Retail Holdings Limited (GOME) (HKEX: 493) in its issuance of US$200 million convertible bonds to be subscribed by Pinduoduo Inc. (NASDAQ: PDD)
• Rock Springs Capital in its cornerstone investment in connection with Innocare Pharma Limited’s (HKEX:9969) Hong Kong IPO.
• WINDMILL Group Limited (HKEX:1850) in respect of its sale of all its issued shares to Standard Dynamic Enterprises Limited (the Offeror) through the mandatory unconditional cash offer made by Altus Capital Limited for and on behalf of the Offeror. 
• Springland International Holdings Limited (HKEX:1700) on its privatization by Octopus (China) Holdings Limited by way of a scheme of arrangement (under section 86 of the Companies Law of the Cayman Islands). DBS Asia Capital Limited acted as the financial advisor to Octopus (China) in this privatization valued at HK$4.5 billion. 
• A biologics technology company in mainland China in its formation of joint venture with an investment subsidiary of Alphabet Inc. and a large Singaporean sovereign fund, whereby the parties will collaborate to (i) localize a platform of proprietary technologies for clinical trial management and data collection, generation, management and analysis in Mainland China and (ii) advance clinical trial management in Greater China. The JV will be set up in Hong Kong.
• CNIC in its establishment of a joint venture with other Chinese investors to facilitate the “one belt one road” investment strategy, and also assistance in its disposal of certain equity in that joint venture to a Hong Kong investor.
• Huatai Capital Finance Limited as lender and financial advisor in connection with the privatization of Enice Holding Company Limited (an ASX-listed company) pursuant to a scheme of arrangement and capital return to be conducted under Hong Kong law.
• Medtronic KL Holdings LLC, a member of the group of Medtronic, in the US$140,000,000 disposal of its entire equity stake in LifeTech Scientific Corporation (a company listed on the Main Board of the Stock Exchange of Hong Kong Limited to China Everbright Limited and another investor.
• Medtronic Inc’s US$66 million strategic investment in LifeTech Scientific Corporation, a GEM-listed company on the Stock Exchange of Hong Kong Limited. Lifetech Scientific is a leading P.R.C-based developer, manufacturer and vendor of advanced minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders.
• Natural Beauty Bio-Technology Limited on the takeover bid by its management, through which the Carlyle Group exited its position in Natural Beauty as investor. 
• CICC, in connection with its subscription of notes issued by HNA Group for purposes of its approximately US$1 billion voluntary general offer of CWT Limited, a Singapore listed integrated logistics solutions provider. Sidley also advised CICC in connection with its role as financial advisor to the offeror in connection with such general offer.
• China Merchants Bank Co., Ltd. as mandated lead arranger on a proposed acquisition facility for a member of the Creat Group in connection with its all-cash offer for the voluntary takeover of Biotest AG, a German pharmaceutical company. Creat is a Chinese investment group that invests in healthcare and pharmaceuticals, manufacturing, energy, finance and natural resources. The takeover was valued at approximately €940 million. 
• China Merchants Bank in connection with its HK$27 billion (approximately US$3.6 billion) financing for the general offer by Dalian Wanda entities of the entire listed share capital of Dalian Wanda Commercial Properties (HKEX:3699). This 2016 high profile transaction is one of the largest privatizations ever to take place in Hong Kong and was recognized by China Law & Practice Awards 2017 as “M&A Deal of the Year”.
• China Orient Asset Management (International) Holding Limited on the formation of a joint venture with Great Eagle Group Limited that will act as the general partners of a U.S. real estate private equity fund that targets to raise up to US$1 billion and a China-focused credit opportunities private equity fund that targets to raise up to US$1 billion.
• China Data Broadcasting Holdings, a GEM listed company on the Stock Exchange of Hong Kong Limited, on its acquisition from Sichuan Changhong Electric, the controlling interests in Changhong IT Information, a leading IT products distributor in Mainland China. The transaction was valued at approximately HK$2 billion and constituted a reverse takeover transaction under the Hong Kong listing rules.
• Guangzhou Shipyard International Company Limited (an A+H share-listed company) in its RMB960 million strategic acquisition of CSSC Guangzhou Longxue Shipbuilding Co., Limited, and its approximately RMB2.2 billion issue of new H shares to various investors. 
• CCB International Securities in its approximately US$220 million loan facility to Hong Kong (Rong An) Investment Limited to finance its proposed takeover of Billion Industrial Holdings Limited.
• CCB International Asset Management Limited in pre-IPO investment in China Aircraft Leasing Group Holdings Limited, a Hong Kong Main Board-listed company. 
• Deutsche Bank and China Merchants Securities, the joint financial advisors,  in connection with the reverse takeover by CIMC Enric on the expansion of its transportation, storage and equipment business through acquisitions in China and Europe, totaling approximately US$540 million.
• China Minsheng Banking Corp., Ltd. as the financier to Liming Holding Limited, through Citigroup Global Markets Asia Limited, in its conditional voluntary partial cash offer to acquire a maximum of 50.5 percent of the issued share capital of AAG Energy Holdings Limited and to cancel a maximum of 50.5 percent of its outstanding options.
• FountainVest in its US$120 million Series B investment jointly with Boyu Capital, and with participation from Celgene Corporation and WuXi Corporate Venture Fund. Antengene is a China-based biopharmaceutical company that focuses on the development and commercialization of novel therapeutics to address high unmet medical needs in China and the Asia-Pacific region. 
  
  

Recent IPO and corporate finance experience include the representation of*:

• China Bright Culture Group in connection with its initial public offering listed on the Main Board of the Stock Exchange of Hong Kong Limited. China Bright Culture Group is a rapidly growing independent producer of variety programs in China. Proceeds: US$116 million.
• Tenfu (Cayman) Holdings Company Limited in connection with its initial public offering and listing on the Main Board of the Stock Exchange of Hong Kong Limited. Tenfu is a leading Chinese tea-product enterprise engaged in the development, sale and marketing of tea products in China. The sponsors and underwriters included Credit Suisse (Hong Kong) Limited and CICC. This transaction was named in 2011 as “Best Small-Cap Equity Deal” by The Asset. Proceeds: US$161 million.
• ManpowerGroup Greater China Limited, in connection with its initial public offering listed on the Main Board of the Stock Exchange of Hong Kong Limited. ManpowerGroup Greater China Limited is a comprehensive workforce solutions and other HR services provider in Greater China. Proceeds: US$ 65.1 million.
• VMS Securities Limited as the sole sponsor in connection with Million Hope Industries Holdings Limited's listing by way of introduction on the Main Board of the Stock Exchange of Hong Kong Limited. Million Hope Industries Holdings Limited and its subsidiaries is a subcontractor principally engaged in the design, supply and installation of facade and curtain wall systems in Hong Kong. 
• Nameson Holdings Limited in connection with its initial public offering listed on the Main Board of the Stock Exchange of Hong Kong Limited. Nameson is a knitwear manufacturer in China. Proceeds: US$77 million.
• Modern Land (China) Company Limited in connection with its initial public offering listed on the Main Board of the Stock Exchange of Hong Kong Limited. Modern Land is a property developer focused on the development of green, energy-saving and eco-friendly residences in China. 
• Citic Securities International, CICC and Guotai Junan International as joint sponsors and underwriters, in connection with the initial public offering of Freetech Road Recycling Technology (Holdings) Ltd listed on the Main Board of the Stock Exchange of Hong Kong Limited. Freetech Road Recycling Technology is a leading and fast-growing service provider using the Hot-in-Place recycling technology in the asphalt pavement maintenance industry in China. 
• HSBC and CCB International as joint lead managers in connection with Ruinian International Limited’s initial public offering listed on the Main Board of the Stock Exchange of Hong Kong Limited. Ruinian International Limited is one of the largest manufacturer of amino acid-based nutritional supplements in China. 
• Angang Steel, a P.R.C. H-share-listed company, in the first dual US$2.6 billion A- and H-share rights issue. 
  
   

*includes matters completed prior to joining Sidley